66 results on '"Pantuck, Allan J."'
Search Results
2. MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study
3. Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinoma
4. Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors
5. Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus—Trends and effect on overall survival
6. Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better?
7. Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma
8. Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
9. Re: Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
10. The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era
11. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection
12. Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma
13. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results
14. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma
15. Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: Safety and feasibility
16. A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer
17. The Role of Adrenalectomy in Renal Cancer
18. Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies
19. Prognostication in localised renal cell carcinoma
20. Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial
21. The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma
22. Pomegranate extract inhibits EMT in clear cell renal cell carcinoma in a NF-κB and JNK dependent manner
23. WITHDRAWN: Pomegranate extract inhibits EMT in clear cell renal cell carcinoma in a NF-κB and JNK dependent manner
24. Intermediate Outcomes and Predictors of Efficacy in the Radiofrequency Ablation of 100 Pathologically Proven Renal Cell Carcinomas
25. Re: Grant D. Stewart, Fiach C. O’Mahony, Alexander Laird, et al. Carbonic Anhydrase 9 Expression Increases with Vascular Endothelial Growth Factor–Targeted Therapy and Is Predictive of Outcome in Metastatic Clear Cell Renal Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.007
26. Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff
27. Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α
28. The effect of gender and age on kidney cancer survival: Younger age is an independent prognostic factor in women with renal cell carcinoma
29. Clinical, Molecular, and Genetic Correlates of Lymphatic Spread in Clear Cell Renal Cell Carcinoma
30. Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
31. Sex, Age, and Surgeon Decision on Nephron-sparing Surgery Are Independent Predictors of Renal Masses With Benign Histologic Findings—A Multicenter Survey
32. Reply
33. Predictive Factors for Ipsilateral Recurrence After Nephron-sparing Surgery in Renal Cell Carcinoma
34. Positive Surgical Margin Appears to Have Negligible Impact on Survival of Renal Cell Carcinomas Treated by Nephron-Sparing Surgery
35. Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF–IGFBP axis
36. Re: Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-Blind, Randomised, Placebo-Controlled Phase III Trial
37. Pathobiology and prognosis of chromophobe renal cell carcinoma
38. Molecular Biology of Renal Cortical Tumors
39. Surveillance for renal cell carcinoma: Why and how? When and how often?
40. Prognostic factors and selection for clinical studies of patients with kidney cancer
41. Platelet Count and Preoperative Haemoglobin Do Not Significantly Increase the Performance of Established Predictors of Renal Cell Carcinoma-Specific Mortality
42. Editorial Comment on: Collecting Duct Renal Cell Carcinoma: A Matched Analysis of 41 Cases
43. Ureteral tumor thrombus from renal cell carcinoma extending into bladder
44. Morbidity and Clinical Outcome of Nephron-Sparing Surgery in Relation to Tumour Size and Indication
45. Prognostic Relevance of Tumour Size in T3a Renal Cell Carcinoma: A Multicentre Experience
46. Differential Diagnosis of Hypercalcemia in Renal Malignancy
47. Editorial Comment on: A Review on Follow-Up Strategies for Renal Cell Carcinoma after Nephrectomy
48. Metastatic Melanoma to the Kidney Presenting with Renal Vein Tumor Thrombus
49. Prevention of Bladder Cancer: A Review
50. Cystic renal cell carcinoma: Biology and clinical behavior
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.